Literature DB >> 25681070

Idiopathic inflammatory myopathies-a review.

Jonathan Jones1, Robert Wortmann.   

Abstract

The idiopathic inflammatory myopathies (IIM) constitute a subset of autoimmune conditions primarily affecting muscle, along with many extra-muscular manifestations. Proximal muscle weakness is the dominant symptom in the IIM. In addition, many patients will have cutaneous manifestations, pulmonary manifestations, and arthritis. There is an increased incidence of malignancy with the IIM. Diagnostic tools beyond history and physical exam include serum muscle enzyme and autoantibody testing, magnetic resonance imaging (MRI) of the extremities, ultrasound, neurologic testing, and muscle biopsy. Several options for treatment are reviewed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25681070     DOI: 10.1007/s10067-015-2891-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  44 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.

Authors:  Jessica E Hoogendijk; Anthony A Amato; Bryan R Lecky; Ernest H Choy; Ingrid E Lundberg; Michael R Rose; Jiri Vencovsky; Marianne de Visser; Richard A Hughes
Journal:  Neuromuscul Disord       Date:  2004-05       Impact factor: 4.296

3.  Contrasting echogenicity in flexor digitorum profundus-flexor carpi ulnaris: a diagnostic ultrasound pattern in sporadic inclusion body myositis.

Authors:  Yu-Ichi Noto; Kensuke Shiga; Yukiko Tsuji; Masaki Kondo; Takahiko Tokuda; Toshiki Mizuno; Masanori Nakagawa
Journal:  Muscle Nerve       Date:  2014-05       Impact factor: 3.217

4.  Therapeutic effect of tocilizumab on two patients with polymyositis.

Authors:  Masashi Narazaki; Keisuke Hagihara; Yoshihito Shima; Atsushi Ogata; Tadamitsu Kishimoto; Toshio Tanaka
Journal:  Rheumatology (Oxford)       Date:  2011-04-22       Impact factor: 7.580

Review 5.  Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.

Authors:  Patrick A Gordon; John B Winer; Jessica E Hoogendijk; Ernest H S Choy
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 6.  Malignancy in myositis.

Authors:  Zaki Abou Zahr; Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

7.  Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan.

Authors:  Daniel E Furst; Anthony A Amato; Şerban R Iorga; Kavita Gajria; Ancilla W Fernandes
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

Review 8.  Imaging: seeing muscle in new ways.

Authors:  Adam Schiffenbauer
Journal:  Curr Opin Rheumatol       Date:  2014-11       Impact factor: 5.006

9.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

Review 10.  Malignancy in patients with inflammatory myopathy.

Authors:  Rachelle Buchbinder; Catherine L Hill
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.686

View more
  6 in total

1.  The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy.

Authors:  Ya-Mei Zhang; Han-Bo Yang; Jing-Li Shi; He Chen; Xiao-Ming Shu; Xin Lu; Guo-Chun Wang; Qing-Lin Peng
Journal:  Clin Rheumatol       Date:  2018-03-15       Impact factor: 2.980

2.  Laboratory Studies in Autoimmune Diseases.

Authors:  Terry L Moore; Austin M Dalrymple
Journal:  Mo Med       Date:  2016 Mar-Apr

3.  Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis.

Authors:  Tao Liu; Ying Hou; Ting-Jun Dai; Chuan-Zhu Yan
Journal:  Chin Med J (Engl)       Date:  2017-09-05       Impact factor: 2.628

4.  Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.

Authors:  Hongya Zhang; Fangyuan He; Ming Shi; Wenxiu Wang; Xiaojia Tian; Juan Kang; Wenjuan Han; Rui Wu; Linfu Zhou; Mengmeng Hu; Xiaobo Li; Fang Mi; Gang Zhao; Hongge Jia
Journal:  Front Neurol       Date:  2017-04-12       Impact factor: 4.003

5.  Muscle assessment using multi-frequency bioimpedance in a healthy Danish population aged 20-69 years: a powerful non-invasive tool in sports and in the clinic.

Authors:  Else Marie Bartels; Eva Littrup Andersen; Jack Kvistgaard Olsen; Lars Erik Kristensen; Henning Bliddal; Bente Danneskiold-Samsøe; Adrian Paul Harrison
Journal:  Physiol Rep       Date:  2019-06

6.  Nephrotic Syndrome as an Extramuscular Manifestation of Anti-EJ Antibody-Positive Dermatomyositis: A Case Report and Review of the Literature.

Authors:  Syoko Tsubouchi; Takahiro Mizuuchi; Yusuke Yamamoto; Daiki Fujimori; Kayo Ishii; Mayu Tago; Eri Kato; Hiroaki Mori; Haeru Hayashi; Koichiro Tahara; Tetsuji Sawada
Journal:  Case Rep Rheumatol       Date:  2022-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.